ZA96797B - Transdermal formulation. - Google Patents

Transdermal formulation.

Info

Publication number
ZA96797B
ZA96797B ZA9600797A ZA96797A ZA96797B ZA 96797 B ZA96797 B ZA 96797B ZA 9600797 A ZA9600797 A ZA 9600797A ZA 96797 A ZA96797 A ZA 96797A ZA 96797 B ZA96797 B ZA 96797B
Authority
ZA
South Africa
Prior art keywords
transdermal formulation
transdermal
formulation
Prior art date
Application number
ZA9600797A
Inventor
Franklin Porter Bymaster
Harlan Edgar Shannon
Lisa Ann Shipley
Kirti Himatlal Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA96797B publication Critical patent/ZA96797B/en

Links

ZA9600797A 1995-02-17 1996-02-01 Transdermal formulation. ZA96797B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39044595A 1995-02-17 1995-02-17

Publications (1)

Publication Number Publication Date
ZA96797B true ZA96797B (en) 1997-08-01

Family

ID=23542480

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9600797A ZA96797B (en) 1995-02-17 1996-02-01 Transdermal formulation.

Country Status (3)

Country Link
AR (1) AR004472A1 (en)
PL (1) PL321827A1 (en)
ZA (1) ZA96797B (en)

Also Published As

Publication number Publication date
PL321827A1 (en) 1997-12-22
AR004472A1 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
HK1011856A1 (en) Cement formulation.
ZA966148B (en) Novel formulation.
ZA962338B (en) Oral 2-methyl-thieno-benzodiazepine formulation.
ZA967315B (en) Biphenylamides.
ZA965190B (en) Pharmaceutical composition.
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
ZA961444B (en) Pyrazolylbenzoyl derivatives.
HK1001852A1 (en) Massager.
MX213417B (en) Phenylpyridazinones.
ZA966075B (en) Protein formulation.
CY2359B1 (en) Pharmaceutical formulation.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
HUP9800832A3 (en) Transdermal formulation
HUP9802070A3 (en) Transdermal formulation
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA968081B (en) Pharmaceutical composition.
ZA96796B (en) Transdermal formulation.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA965494B (en) Therapeutic agents.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.
ZA967314B (en) Carbamoylcarboxamides.